首页 正文

Rituximab in adult minimal change disease and focal segmental glomerulosclerosis

{{output}}
Treatment of nephrotic syndrome due to minimal change disease and focal segmental glomerulosclerosis remains a challenge since steroid dependence, steroid resistance and a relapsing disease course exhibits a high cumulative steroid dosage. The necessity of usi... ...